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The pathophysiologic mechanisms of atrial fibrillation
(AF), characterized by disorganized and high rates 
of atrial electrical activity, have been extensively
explored during the past decade. The ectopic and
focal firing activities within atrial tissues or thoracic
veins may initiate AF, which requires favorable sub-
strates for its maintenance and self-perpetuation in
the fashion of multiple re-entry circuits with spatial
and temporal variability [1]. The adaptation of atrial
tissues to the rapid fibrillatory rhythm has been
referred to as atrial remodeling, which includes the
processes of both structural and electrical remodeling
(ER) [2,3].
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Atrial electrical remodeling (ER) after spontaneous or pacing-induced atrial fibrillation has been
previously described in humans. We investigated atrial ER induced by a 5-minute period of rapid
atrial pacing and the pharmacologic effects of verapamil and procainamide on this atrial ER phe-
nomenon. The atrial effective refractory periods (ERPs) at drive cycle lengths of 400 (ERP400) and 600
(ERP600) ms, at five representative atrial sites (high right atrium [HRA]; proximal, middle and distal
coronary sinus; interatrial septum), were determined in 20 patients at baseline and immediately after
cessation of a 5-minute period of rapid pacing from the HRA at a rate of 150 bpm. The degrees of
atrial ERP400 and ERP600 shortening after pacing were calculated as acute atrial ER. The same proto-
col was repeated in another 15 patients after intravenous administration of verapamil (0.15 mg/kg)
and in another 15 patients after intravenous administration of procainamide (15mg/kg). The results
demonstrated that, in the control state acute atrial ER can be significantly demonstrated at each
atrial representative site (p<0.001). The mean ERP400 and ERP600 shortenings were 9±4% and 8±4%,
respectively. After procainamide infusion, but not after verapamil, baseline ERP400 and ERP600
values were significantly prolonged at the five representative atrial sites (p < 0.01). Acute atrial ER
could still be demonstrated at each atrial site after procainamide or verapamil infusion (p < 0.001).
In conclusion, acute atrial ER can be demonstrated after only a 5-minute period of rapid atrial
pacing in humans. Intravenous verapamil or procainamide does not abolish this ER process.
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The concept that “AF begets AF”, first demon-
strated in a goat experimental study by Wijffels et al,
highlighted the important roles of ER in both short-
and long-term rapid atrial rates [4]. Subsequent studies
in animal models, using artificially rapid atrial pacing
within days or weeks, have shown that ion remodel-
ing is substantially involved in the process of ER [3,5].
In human studies, ER was previously demonstrated by
measuring the changes in atrial electrophysiologic pro-
perties immediately after the termination of AF [6–9].
Both electrical cardioversion of paroxysmal/per-
sistent AF and spontaneous conversion of short-term
pacing-induced AF have been utilized to detect atrial
ER induced by rapid atrial rates [7–10]. However, the
potential limitation of the former method lies in the
possibility that the alteration of atrial electrophysio-
logic characteristics observed immediately after elec-
trical cardioversion may represent not only the effect
of AF, but also that of electrical cardioversion itself.
In human studies by Daoud et al using the latter
method, several minutes of pacing-induced AF fol-
lowed by spontaneous conversion sufficiently short-
ened the atrial ERP within minutes, and such
changes in atrial electrophysiologic properties were
markedly attenuated by pretreatment with vera-
pamil, but not with procainamide [6,7].
Although the roughly 10-fold increase in atrial rate
caused by AF has previously been shown to be the
primary stimulus leading to ER, similar changes can
also be produced by other forms of clinically rapid
atrial tachyarrhythmia [11–14]. In this study, we fur-
ther explore the manifestation of ER using rapid atrial
pacing with a rate and period easily tolerated by
humans. Accordingly, the aims of this study were: (1)
to determine whether rapid atrial pacing at a rela-
tively slow rate (150 bpm) and over a short period 
(5 minutes) could induce atrial ER in humans; and (2) to
determine the pharmacologic effects of verapamil and
procainamide (representative calcium and sodium
channel blockers, respectively) on the manifestations of
atrial ER induced by 5 minutes of rapid atrial pacing.
METHODS
Study patients
A total of 50 patients (28 female, 22 male; mean age,
52 ± 11 years) without structural heart diseases were
referred to the Kaohsiung Medical University Hospital
for electrophysiologic study due to paroxysmal
supraventricular tachycardia and/or radiofrequency
catheter ablation. Common forms of slow-fast atrio-
ventricular nodal re-entrant tachycardia and atrioven-
tricular reciprocating tachycardia using a concealed
accessory pathway were disclosed in 32 and 18
patients, respectively. No history of paroxysmal AF
was documented in any patient.
Electrophysiologic study
Electrophysiologic studies were performed in patients
in a non-sedative and fasting state. All antiarrhyth-
mic agents had been discontinued for a minimum of
five elimination half-lives. No patients were treated
with amiodarone. Using a conventional method, three
quadripolar electrode catheters were introduced into
the high right atrium (HRA), right AV junction and
right ventricular apex for both recording and stimu-
lation. Another decapolar electrode catheter with 2mm
intraelectrode and 5 mm interelectrode distances was
introduced into the coronary sinus with the proximal
pair of electrodes located at the coronary sinus ori-
fice. Standard techniques for recording and stimulation
were performed. The study protocol was approved
by the institutional review board and was performed
with the patients’ informed consent after completion
of the clinically indicated portion of the electrophysi-
ologic procedure (Figure 1).
Baseline study
A baseline study for determining changes in the atrial
effective refractory period (ERP) after rapid atrial
pacing from the HRA was performed in 20 patients
(11 female, mean age 56±8 years). All patients received
intravenous propranolol at a dose of 0.1 mg/kg over
a period of 5 minutes, in order to decrease the inter-
ference from reflex sympathetic activity induced by
rapid atrial pacing. The ERPs of the atrium were deter-
mined at the following sites: HRA, proximal coronary
sinus (PCS), middle coronary sinus (MCS) and distal
coronary sinus (DCS). The interatrial septum (IAS) was
also included in part of this study protocol, before and
after intravenous administration of verapamil or pro-
cainamide. The mean atrial capture threshold was
0.8 ± 0.2 mA. Stimuli were delivered as rectangular
pulses of 2-ms duration, at twice the diastolic threshold.
Atrial ERPs were measured using the S1S2 method
at the representative sites, at basic drive cycle lengths
of 400 (ERP400) and 600 (ERP600) ms, for eight beats,
with a 2-second pause between pacing trains. The
S1S2 coupling interval was decreased by 10-ms incre-
ments until loss of atrial capture; then, S2 extra stimuli
were applied with 1-ms increments until the S2 stim-
ulus recaptured the atrial tissue. The ERP was defined
as the longest S1S2 coupling interval that failed to
result in atrial capture. The mean durations from the
end of rapid atrial pacing to the last capture in ERP400
and ERP600 were 58 ± 12 seconds and 76 ± 15 seconds,
respectively. Atrial dispersion was calculated as the
difference between the maximal and minimal ERPs
(atrial dispersion = ERPmax − ERPmin) among all of the
representative atrial sites described above [15].
Acute electrical remodeling after 
5 minutes of rapid atrial pacing
After baseline atrial ERP400 and ERP600 were deter-
mined, acute ER was induced by rapid atrial pacing
from the HRA, at 150 bpm, for 5 minutes. The ERP400
of the HRA was determined immediately after stop-
ping the rapid atrial pacing and compared with base-
line. Then, rapid atrial pacing from the HRA was
performed repeatedly, at 150 bpm, for another 5 min-
utes. The ERP600 of the HRA was determined once
again, immediately after cessation of rapid atrial pac-
ing. The corresponding ERP400 and ERP600 of PCS,
MCS and DCS were subsequently determined each
time, immediately after stopping rapid atrial pacing.
Changes in atrial ERP and their dispersions between
baseline and immediately after cessation of a 5-minute
period of rapid atrial pacing were referred to as acute
atrial ER.
Effects of procainamide
After determining the atrial ERP400 and ERP600 at all
representative sites, both in the control state and after
rapid atrial pacing at 150 bpm for 5 minutes, intra-
venous procainamide at a dose of 15 mg/kg was
given at a rate of 50 mg/min, followed by a mainte-
nance dose of 4mg/min, to 15 patients (8 female, mean
age 51 ± 11 years). After intravenous administration
of procainamide, the ERP400 and ERP600 of each repre-
sentative atrial site were determined. The same pro-
tocol for determining atrial ERPs was repeated
immediately after rapid atrial pacing at 150 bpm for 
5 minutes. The changes in ERP at each representative
atrial site were compared before and after intravenous
administration of procainamide.
Effects of verapamil
Intravenous verapamil at a dose of 0.15 mg/kg 
was administered to 15 patients (9 female, mean age
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Figure 1. Flow diagram of the study protocol. *Measurement of the atrial effective refractory period (ERP400 and ERP600) from the
high right atrium (HRA), proximal (PCS), middle (MCS) and distal (DCS) coronary sinuses and interatrial septum (IAS); †measure-
ments of ERPs (ERP400 and ERP600) from the HRA, PCS, MCS and DCS. Changes in atrial ERPs and atrial dispersions between
baseline and immediately after cessation of a 5-minute period of rapid atrial pacing represent acute electrical remodeling.
54 ± 9 years) over a period of 3–5 minutes, followed by
continuous infusion at a dose of 0.005 mg/kg/min.
The same protocol for determining the atrial ERPs at
representative atrial sites as described above was per-
formed both in the control state and immediately after
rapid atrial pacing at 150 bpm for 5 minutes. The
changes in ERP at each representative atrial site were
compared before and after intravenous administration
of verapamil.
Statistical analysis
Continuous variables are expressed as mean±standard
deviation. Comparisons between continuous variables
were made using the paired t test. A value of p < 0.05
was considered to be significant. Statistical analysis
was performed with SPSS version 11.0 (SPSS Inc.,
Chicago, IL, USA).
RESULTS
Acute electrical remodeling
The mean atrial ERP400 and ERP600 of the HRA, PCS,
MCS and DCS in 20 patients are summarized in Table 1
and illustrated in Figure 2. The mean dispersion of
atrial refractoriness at a pacing cycle length of 400 ms
and 600 ms was 30±17 ms and 34±14 ms, respectively.
After a 5-minute period of rapid atrial pacing at a rate
of 150 bpm, the ERP400 values of the HRA were signif-
icantly shortened from 232 ± 29 ms to 211 ± 29 ms. In
addition, the ERP400 and ERP600 values of the HRA,
PCS, MCS and DCS were all significantly shortened
(all p < 0.001; Table 1 and Figure 2). However, no sig-
nificant changes in the spatial dispersion of atrial
refractoriness could be demonstrated.
Effects of procainamide on acute 
electrical remodeling
Before procainamide infusion, acute atrial ER could be
demonstrated at each representative atrial site follow-
ing a 5-minute period of rapid atrial pacing at 150bpm,
in all 15 patients (all p < 0.001, Table 2 and Figure 3).
After intravenous administration of procainamide, the
baseline ERP400 values of the HRA, PCS, MCS, DCS and
IAS were significantly prolonged from 215 ± 17 ms to
249 ± 21 ms, 227 ± 18 ms to 244 ± 22 ms, 225 ± 15 ms to
242 ± 21 ms, 223 ± 19 ms to 236 ± 17 ms and 226 ± 16 ms
to 256±21ms, respectively (all p<0.01). Significant pro-
longation of the baseline ERP600 in the atrium at the
five representative atrial sites was also demonstrated
(all p < 0.01). After rapid atrial pacing for 5 minutes
following procainamide infusion, the ERP400 values of
the HRA, PCS, MCS, DCS and IAS were significantly
shortened from 249 ± 21 ms to 207 ± 19 ms, 244 ± 22 ms
to 218 ± 22 ms, 242 ± 21 ms to 218 ± 20 ms, 236 ± 17 ms
to 214 ± 15 ms and 256 ± 21 ms to 229 ± 20 ms, respec-
tively (all p<0.001). In addition, significant shortening
of the ERP600 at the five representative atrial sites was
also demonstrated (all p < 0.001; Table 2 and Figure 3).
These results indicate that, although intravenous pro-
cainamide significantly prolongs baseline atrial ERPs,
it cannot prevent the shortening of ERPs induced by
short-term rapid atrial pacing. No significant changes
in atrial dispersion were noted in the control state or
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Table 1. Acute atrial electrical remodeling after 5-minute rapid atrial pacing (n = 20)
Sites Baseline Post-pacing Shortening (%) p
ERP400
HRA 232 ± 29 211 ± 29 9 ± 5 < 0.001
PCS 233 ± 19 214 ± 19 8 ± 2 < 0.001
MCS 221 ± 18 207 ± 17 6 ± 3 < 0.001
DCS 227 ± 16 210 ± 19 12 ± 5 < 0.001
Atrial dispersion 30 ± 17 30 ± 16 0.853
ERP600
HRA 234 ± 29 215 ± 32 9 ± 5 < 0.001
PCS 235 ± 22 218 ± 20 7 ± 5 < 0.001
MCS 240 ± 28 222 ± 25 7 ± 3 < 0.001
DCS 247 ± 20 228 ± 23 8 ± 3 < 0.001
Atrial dispersion 34 ± 14 37 ± 17 0.798
All patients were given intravenous propranolol at a dose of 0.1 mg/kg. ERP = effective refractory period; HRA = high right atrium;
PCS = proximal coronary sinus; MCS = middle coronary sinus; DCS = distal coronary sinus.
after rapid atrial pacing, with or without the drug
effects of procainamide.
Effects of verapamil on acute atrial
electrical remodeling
Before verapamil infusion, acute atrial ER induced by
5-minute rapid atrial pacing was demonstrated in
another 15 patients (9 female, mean age 49 ± 12 years)
(Table 3 and Figure 4). After intravenous administration
of verapamil, the baseline ERP400 and ERP600 values for
the HRA, PCS, MCS, DCS and IAS showed no signifi-
cant change. However, after a 5-minute period of rapid
atrial pacing under verapamil infusion, the ERP400 and
ERP600 values in all five representative atrial sites were
significantly shortened (all p < 0.001; Table 3 and
Figure 4). No significant changes in atrial dispersion
Electrical remodeling by rapid atrial pacing
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Figure 2. In the control state, the atrial effective refractory periods at a driving cycle length of (A) 400 ms (ERP400) and (B) 600 ms
(ERP600) at four atrial representative sites are significantly shortened right after a 5-minute period of rapid atrial pacing at a rate of
150 bpm. *p < 0.001. HRA = high right atrium; PCS = proximal coronary sinus; MCS = middle coronary sinus; DCS = distal coronary
sinus; RAP = rapid atrial pacing.
were noted in control states or after rapid atrial pacing,
with or without the drug effects of verapamil.
DISCUSSION
Main findings
In this study, we demonstrated that atrial ERP could
be significantly shortened after only a 5-minute period
of rapid atrial pacing from the HRA, at a rate of
150 bpm. This finding indicates that acute atrial ER can
occur even in the presence of short-term, modest heart
rate changes. In addition, we demonstrated that,
although intravenous procainamide can significantly
prolong baseline atrial ERP, it cannot attenuate the
degree of atrial ER induced by a 5-minute period of
rapid atrial pacing. On the other hand, intravenous
verapamil neither significantly changed baseline
atrial ERPs nor abolished the acute atrial ER induced
by a 5-minute period of rapid atrial pacing. Finally,
we found that the spatial dispersion of atrial refrac-
toriness was not affected by short-term atrial rapid
pacing.
Tachycardia-induced atrial 
electrical remodeling
Previous clinical studies have demonstrated that any
form of atrial tachyarrhythmia, including AF, atrial
flutter and atrial tachycardia, can lead to a progressive
shortening of atrial ERP and an increased susceptibility
to AF development [11–14]. Atrial ER can be observed,
even in the setting of spontaneous or artificially paced
tachycardias of short or long durations [6,7,14].
Previous literature also demonstrated that atrial ERP
could be shortened after rapid atrial pacing at pacing
cycle lengths in the range of 250–400 ms for 10 minutes
[13,16]. However, the shortening of the atrial ERP
induced by such a short-term rapid atrial pacing may
partially be explained by increases in sympathetic
tone caused by the rapid atrial pacing rates. In this
study, in the presence of intravenous propranolol,
shortening of atrial ERP after 5 minutes of atrial pac-
ing could still be demonstrated, indicating that the
development of atrial ER induced by such a short-
term rapid atrial pacing may not result from reflex
sympathetic activity.
Effects of verapamil on atrial remodeling
Many reports have demonstrated that tachycardia-
induced atrial remodeling is due to decreases in the
action potential duration (APD) of atrial cells [17–19].
Shortening of the APD leads to a parallel decrease in
the atrial ERP and a subsequent shortening of the
wavelength for re-entry to occur [19,20]. Many types
of ion channels, such as L-type calcium channels or
Ito, IKur, IKr, IKs and IKAch potassium channels, have
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Table 2. Effect of procainamide on acute atrial electrical remodeling (n = 15)
Before procainamide After procainamide
Sites
Baseline Post-pacing Shortening (%) Baseline Post-pacing Shortening (%)
ERP400
HRA 215 ± 17 191 ± 19* 11 ± 4 249 ± 21† 207 ± 19* 17 ± 4
PCS 227 ± 18 197 ± 16* 9 ± 3 244 ± 22† 218 ± 22* 11 ± 2
MCS 225 ± 15 205 ± 13* 9 ± 2 242 ± 21† 218 ± 20* 10 ± 3
DCS 223 ± 19 194 ± 18* 12 ± 7 236 ± 17† 214 ± 15* 9 ± 3
IAS 226 ± 16 209 ± 19* 8 ± 3 256 ± 21† 229 ± 20* 11 ± 3
Atrial dispersion 37 ± 15 37 ± 15 38 ± 17 39 ± 17
ERP600
HRA 227 ± 29 209 ± 26* 8 ± 3 260 ± 23† 211 ± 22* 18 ± 8
PCS 227 ± 25 207 ± 22* 9 ± 4 251 ± 24† 227 ± 21* 10 ± 2
MCS 225 ± 28 218 ± 16* 9 ± 3 255 ± 17† 224 ± 17* 12 ± 1
DCS 234 ± 9 213 ± 14* 9 ± 3 250 ± 16† 224 ± 12* 10 ± 2
IAS 230 ± 16 211 ± 15* 8 ± 2 262 ± 21† 232 ± 18* 12 ± 3
Atrial dispersion 36 ± 17 36 ± 18 34 ± 14 38 ± 17
*p < 0.001 represents a significant difference between baseline and pacing; †p < 0.01 represents a significant difference in baseline ERP
before and after procainamide administration. ERP = effective refractory period; HRA = high right atrium; PCS = proximal coronary
sinus; MCS = middle coronary sinus; DCS = distal coronary sinus; IAS = interatrial septum.
been reported to be involved in the shortening of
atrial APD [19–23]. Tachycardia-induced intracellular
calcium overload has been proposed to be one of the
mechanisms involved in both electrical and structural
remodeling [1,3,18,24]. Previous animal and human
studies have demonstrated that pretreatment with
calcium channel blockers can significantly attenuate
or prevent the shortening of atrial ERP induced by
rapid atrial pacing or paroxysmal AF [3,25]. However,
the effects of verapamil on the atrial electrical proper-
ties in humans are still controversial because both
attenuation of and no change in tachycardia-induced
atrial ERP shortening have been previously reported
[26–28]. These differences may result from the timing
Electrical remodeling by rapid atrial pacing
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Figure 3. After intravenous administration of procainamide, the (A) ERP400 and (B) ERP600 of all atrial representative sties are signif-
icantly prolonged (*p < 0.01). In the control state, electrical remodeling manifested by significant shortening of the ERP400 and ERP600
at all atrial representative sites was seen after rapid atrial pacing. Intravenous procainamide could not abolish the shortening of atrial
refractoriness after rapid atrial pacing. †p < 0.001. HRA = high right atrium; PCS = proximal coronary sinus; MCS = middle coronary
sinus; DCS = distal coronary sinus; IAS = interatrial septum; RAP = rapid atrial pacing.
of verapamil administration and the duration of
rapid atrial pacing or AF.
Daoud et al evaluated electrical remodeling after
pacing-induced short-term AF by determining the
changes in pre-AF and post-AF atrial refractoriness [6].
These authors also demonstrated that verapamil can
markedly attenuate the ER process by altering atrial
ERP, possibly by preventing calcium overload during
AF [7]. Although similar degrees of shortening of atrial
ERPs after rapid atrial pacing were found in our study
and that of Daoud et al, verapamil did not prevent the
shortening of atrial ERPs induced by 5-minute rapid
atrial pacing in the present study. Possible explana-
tions for this discrepancy might be related to: (1) the
rate-dependency of tachycardia-induced changes in
atrial ERPs [13,27]; (2) different regularities between
these two different methods; or (3) differences in the
mechanisms of cytoplasmic/mitochondrial calcium
overload within atrial tissues in response to short-term
AF versus short-term rapid atrial pacing [29]. Further
studies to investigate the cellular effects of these two
different methods on the mechanisms underlying
atrial ERP changes might be warranted.
Effects of procainamide on atrial 
electrical remodeling
The electrophysiologic effects of procainamide are
mediated both by procainamide itself and the active
metabolite N-acetyl procainamide, which blocks
sodium channels (INa), and also the rapidly activating
component of the delayed rectifying current (IKr)
[30,31]. These effects result in prolongation of the repo-
larization and ERP of both atrial and ventricular tissue.
In this study, intravenous procainamide significantly
prolonged the atrial ERP, consistent with the electro-
physiologic effects of procainamide in humans
reported previously [31]. After 5 minutes of rapid atrial
pacing under procainamide, the atrial ERP could still
be shortened significantly. This result indicates that,
although procainamide can significantly prolong atrial
ERP, it cannot attenuate or prevent the occurrence of
atrial ER induced by short-term rapid atrial pacing.
The degrees of shortening of atrial ERPs after rapid
atrial pacing were similar in controls and patients
administered intravenous procainamide, concordant
with the study by Daoud et al using pacing-induced
AF; this may indicate that neither INa nor IKr plays a
significant role in the generation of atrial ER induced
by short-term rapid atrial pacing [7].
Study limitations
Several limitations of this study need to be mentioned.
First, most of the patients had no previous history of
AF or significant organic heart diseases. Thus, the
results of this study may not apply to patients with
organic heart disease or patients with paroxysmal AF.
Second, the electrophysiologic properties of right and
left atrial tissue might be heterogeneous. Although we
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Table 3. Effect of verapamil on acute atrial electrical remodeling (n = 15)
Control Verapamil
Sites
Baseline Pacing Shortening (%) Baseline Pacing Shortening (%)
ERP400
HRA 212 ± 15 192 ± 15* 9 ± 4 214 ± 20 199 ± 20* 7 ± 2
PCS 208 ± 16 191 ± 15* 8 ± 2 209 ± 14 193 ± 12* 8 ± 4
MCS 204 ± 14 191 ± 14* 6 ± 2 205 ± 12 191 ± 13* 7 ± 2
DCS 218 ± 12 200 ± 12* 8 ± 4 217 ± 12 201 ± 11* 7 ± 3
IAS 218 ± 15 200 ± 19* 8 ± 4 217 ± 16 203 ± 15* 6 ± 2
Atrial dispersion 33 ± 12 34 ± 16 35 ± 14 33 ± 13
ERP600
HRA 231 ± 16 205 ± 17* 12 ± 3 234 ± 21 210 ± 17* 10 ± 2
PCS 221 ± 15 211 ± 17* 5 ± 4 226 ± 15 208 ± 15* 8 ± 2
MCS 219 ± 14 203 ± 13* 7 ± 1 230 ± 11 211 ± 12* 8 ± 2
DCS 236 ± 13 216 ± 15* 9 ± 3 233 ± 14 220 ± 14* 6 ± 2
IAS 233 ± 15 216 ± 14* 7± 2 231 ± 16 219 ± 16* 5 ± 3
Atrial dispersion 36 ± 14 39 ± 12 35 ± 13 37 ± 12
*p < 0.001 represents a significant difference between baseline and pacing. ERP = effective refractory period; HRA = high right atrium;
PCS = proximal coronary sinus; MCS = middle coronary sinus; DCS = distal coronary sinus; IAS = interatrial septum.
measured the atrial ERPs from five representative sites,
the results cannot represent the electrophysiologic
properties of entire atrial tissues. Third, in this study,
all patients were administered propranolol before
atrial pacing to attenuate sympathetic effects on atrial
ERP. Full autonomic blockade through the addition
of atropine was not performed in the present study.
Clinical implications
In this study, we demonstrated that acute atrial ER
could occur even after a 5-minute period of rapid
atrial pacing, which may indicate that subclinical
short-term atrial tachyarrhythmias can induce tran-
sient atrial ER. In addition, this acute atrial ER could
not be suppressed by sodium or calcium channel
Electrical remodeling by rapid atrial pacing
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Figure 4. After intravenous administration of verapamil, no significant differences in (A) ERP400 and (B) ERP600 could be demon-
strated at any atrial representative site (p = NS). In the control state, electrical remodeling manifested by significant shortening of
ERP400 and ERP600 at all atrial representative sites was seen after rapid atrial pacing. Intravenous verapamil could not prevent the
shortening of atrial refractoriness after rapid atrial pacing. *p < 0.001. HRA = high right atrium; PCS = proximal coronary sinus; 
MCS = middle coronary sinus; DCS = distal coronary sinus; IAS = interatrial septum; RAP = rapid atrial pacing.
blockers. Since many patients may have episodes of
silent short-term atrial tachyarrhythmias, the acute
atrial ER induced by such short-term atrial tach-
yarrhythmias might accumulate and progressively
contribute to the pathogenesis of clinically docu-
mented atrial arrhythmias.
In summary, atrial ER can be demonstrated 
after only a 5-minute period of modest rapid atrial
pacing at a rate of 150 bpm in humans. This acute
atrial ER induced by short-term rapid atrial pacing 
is not abolished by calcium or sodium channel 
blockers.
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